G3 (Retatrutide 40mg)

Retatrutide is an investigational triple agonist compound that simultaneously targets GIP, GLP-1, and glucagon receptors. It is being explored in research for its potential in treating obesity and metabolic disorders. This compound is experimental and intended for research use only.

Due to the nature of our products/services, we do not provide refunds under any circumstances. All purchases are final.